knowledge -WSS

knowledge

author：explore 2025-08-11 07:59:08 - browse：24627

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Elevance PBM president out as customers face prescription chaos

leisure time

WSS

STAT wants to know your pick for a great summer read or listen

Medicare Advantage's lean provider networks lead CMS complaints

FDA approves Moderna’s RSV vaccine, its second licensed product

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Medicare Advantage's lean provider networks lead CMS complaints

Elevance PBM president out as customers face prescription chaos

hotspot

knowledge

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Dobbs anniversary: the lost opportunity of abortion as health care

Fatty liver disease was alleviated by Lilly’s ‘triple

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Structure Therapeutics oral GLP

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

An outdated Medicare rule harms dementia patients with anxiety

Trump demands the U.S. pay no more for drugs than other countries … again

A letter from the executive editor: The 2023 STATUS List

leisure time

Fatty liver disease was alleviated by Lilly’s ‘triple

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Senators tussle over abortion against the backdrop of a presidential campaign

Crowdfunding for unproven stem cell procedures spreads misinformation

A new initiative will help leaders fight the next pandemic

A letter from the executive editor: The 2023 STATUS List

Wikipedia

leisure time

hotspot

leisure time